Document is current

Article History

Received: 14 June 2025

Accepted: 8 November 2025

First Online: 8 January 2026

Declarations

:

: BW is Principal Investigator on the following CRADAs (Cooperative Research & Development Agreements) between NIH and industry: Philips (CRADA), Philips Research (CRADA), Celsion Corp (CRADA), BTG Biocompatibles / Boston Scientific (CRADA), Siemens (CRADA), NVIDIA (CRADA), XAct Robotics (CRADA). ProMaxo (CRADA), Theromics, Imactis, Canon Medical, Varian, MediView, URO-1, Immunophotonics (pending), Deepsight. The following industry partners also support the research of BW via equipment, personnel, devices and/ or drugs: 3 T Technologies (devices), Exact Imaging (data), Angiodynamics (equipment), Astra Zeneca (pharmaceuticals, NCI CRADA), ArciTrax (devices and equipment), Imactis (Equipment), Johnson and Johnson (equipment), Medtronic (equipment), Theromics (Supplies), Profound (equipment and supplies), QT Imaging (equipment and supplies), Medtronic (equipment), Boston Scientific (equipment), Varian (materials), Combat Medical (equipment), Clinical LaserThermia Systems (equipment), MediView (equipment), CIVCO Medical Solutions (equipment), Galvanize, Alessa Therapeutics (NCI CRADA or CTA), Immunophotonics (supplies). Philips and NIH have a patent licensing agreement under which NIH receives royalties, a portion of which are then given to BW. NVIDIA and NIH have a licensing agreement. NIH and Canon have a licensing agreement. NIH and CIVCO are co-inventors on IP. NIH and ArciTrax are co-inventors on IP. NIH and Philips are co-inventors on IP. NIH and Boston Scientific are co-inventors on IP. NIH and NVIDIA are co-inventors on IP. The views, information or content, and conclusions presented do not necessarily represent the official position or policy of, nor should any official endorsement be inferred on the part of, the Clinical Center, the National Institutes of Health, or the Department of Health and Human Services.